OptiNose, Inc. (NASDAQ:OPTN) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Stay updated with breaking news from David Amsellem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
AXSM earnings call for the period ending March 31, 2024.
Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.29824 EPS, expectations were $0.09. Amneal Pharmaceuticals, Inc.
Corrected Transcript 02-May-2024 Organon & Co. Q1 2024 Earnings Call ...
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.